SMS PHARMACEUTICALS
|
The Current P/E Ratio of SMS PHARMACEUTICALS is 36.29.
Share Price | ₹251.0 | Nov 19,2024 |
Market Cap | ₹2,125.5 Cr | |
Earnings-TTM | ₹58.6 Cr | TTM-Consolidated Results |
Price/Earnings | 36.29x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SMS PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹2,125.5 Cr] as on Nov 19,2024
(/) Earnings [ ₹58.6 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 36.29x ]
Thus, for SMS PHARMACEUTICALS , the investors are currently willing to pay 36.29 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SMS PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SMS PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of SMS PHARMACEUTICALS
PE Ratio Performance Analysis for SMS PHARMACEUTICALS
- SMS PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 13.40x.
- SMS PHARMACEUTICALS 's operated at median p/e ratio of 12.76x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SMS PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 30.25x.
- SMS PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does SMS PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SMS PHARMACEUTICALS | 58.58 | 36.29 | 2,125.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 38.25 | 425,930.0 |
CIPLA LTD | 4,485.22 | 26.39 | 118,368.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 18.43 | 99,671.4 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.16 | 95,280.3 |
DIVIS LABORATORIES LTD | 1,836.00 | 86.40 | 158,636.0 |
MANKIND PHARMA LTD | 2,124.86 | 48.42 | 102,890.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 58.13 | 104,742.0 |
LUPIN LTD | 2,651.94 | 35.04 | 92,929.7 |
AUROBINDO PHARMA LTD | 3,598.83 | 19.69 | 70,869.4 |
ABBOTT INDIA LTD | 1,284.66 | 44.90 | 57,681.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SMS PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.43x |
Max industry PE | 86.40x |
Median industry PE | 36.29x |
Average industry PE | 39.46x |
You may also like the below Video Courses